An Investigation on a Novel Anti-tumor Fusion Peptide of FSH(33-53)-IIKK

A novel fusion peptide FSH(33-53)-IIKK was designed and expected to combine the follicle stimulating hormone receptor (FSHR) targeting and tumor toxicity. In vitro and in vivo study showed the anti-tumor activity of FSH(33-53)-IIKK was enhanced compared to that of IIKK only. FSH(33-53)-IIKK could in...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Runlin, Liu, Ping, Pan, Donghui, zhang, Pengjun, Bai, Zhicheng, Xu, Yuping, Wang, Lizhen, Yan, Junjie, Yan, Yongjun, Liu, Xingdang, Yang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910594/
https://www.ncbi.nlm.nih.gov/pubmed/27313792
http://dx.doi.org/10.7150/jca.14425

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4910594/
https://www.ncbi.nlm.nih.gov/pubmed/27313792
http://dx.doi.org/10.7150/jca.14425

Ejemplares similares